IV fluids used by NHS responsible for unnecessary deaths

Starch-based intravenous (IV) fluids used by the NHS to treat seriously ill patients are causing unnecessary deaths, according to a new Cochrane systematic review by researchers at the London School of Hygiene & Tropical Medicine.

Based on data from 25 randomised control trials, the researchers concluded that starch-based colloid fluids, used to stabilise patients with low blood pressure, are not only more expensive than saline-based crystalloid fluids, but may also be causing around 250 unnecessary deaths in the UK every year.

The study included 9,147 seriously ill patients after trauma, burns and surgery or those with severe infections who were randomly allocated to receive either colloid fluids or saline fluids in their resuscitation. Those receiving colloids were 10% more likely to die. The researchers are now calling on the NHS to stop using colloid fluids.

Lead author Dr Ian Roberts, director of the clinical trials unit at the London School of Hygiene & Tropical Medicine, said: "Starch solutions are widely used in the NHS and the evidence from our study shows that they kill patients. They are more expensive than saline and they increase the risk of death. British hospitals use far more starch solutions than most other countries. The ongoing use of colloids is unjustified."

The safety of using colloids containing hydroxyethyl starch has been debated for years. They are widely used to treat shock following severe blood loss by increasing blood volume but recent large high quality studies have linked starch use to renal failure. The trials also found more adverse reactions with starch. Crystalloids work in the same way but do not contain starch.

The European Medicines Agency is conducting a review into the safety of hydroxyethyl starch in critically ill patients but Dr Roberts believes that the NHS should take action now and has written to the Department of Health. He said: "We don't need to wait for starch solutions to be banned in order to take action in the NHS. We have a safer, less expensive alternative that is widely used around the world. The should take action now."

More information: Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD000567. DOI: 10.1002/14651858.CD000567.pub6

add to favorites email to friend print save as pdf

Related Stories

Controlling starch in sugar factories

Jun 09, 2011

Factory trials conducted by U.S. Department of Agriculture (USDA) scientists have led to recommendations for controlling or preventing starch buildup in processed raw sugars and products made with those sugars. The study ...

Recommended for you

Running really can keep you young, study says

2 hours ago

If you are an active senior who wants to stay younger, keep on running. A new study involving the University of Colorado Boulder and Humboldt State University shows that senior citizens who run several times ...

The American athletics track is still a man's world

3 hours ago

The limited coverage that American female athletes get in the media is one of many subtle forms of gender biases they have to cope with. The little exposure they do get often focuses more on their attire, or how attractive, ...

How do teenage boys perceive their weight?

5 hours ago

Almost one third of male adolescents inaccurately perceive their weight. This can influence their eating habits and, consequently, their health, according to a study led by the UAB and conducted with 600 teenage boys from ...

Cold front sparks dangerous use of space heaters

5 hours ago

The Consumer Product Safety Commission (CPSC) estimates that more than 25,000 residential fires and more than 300 deaths are caused each year by space heaters. More than 6,000 Americans receive hospital emergency room care ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.